Clear and non ambiguous positive outcome would have been a good...

Clear and non ambiguous positive outcome would have been a good start. The management have seemingly put a lot of effort into this meeting and emphasised the importance of it numerous times. In fact the meeting was originally slated for June but was delayed. I for one was disappointed that the primary efficacy end point was not agreed on at the meeting. The market sentiment was already negative towards Neuren and I was hoping the management was able to ace this one. Unlike Daybue sales, this is well within their control